(Q44051276)

English

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

author name string

Fuad S Shihab

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

William M Bennett

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hong Yi

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Takeshi F Andoh

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

111-119

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Pirfenidone attenuates bleomycin-induced changes in pulmonary functions in hamsters

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

21 January 2018

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic progressive interstitial fibrosis in renal disease--are there novel pharmacological approaches?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020201.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-6143.2002.020201.X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44051276&oldid=2106027810"